Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC
Clinical trial NCT05781958 · UNKNOWN
Trial details
- NCT number
- NCT05781958
- Sponsor
- Shen Feng
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-24
- Primary completion
- 2023-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.